Ai Market Access

Market Access Strategy Research

Doctoral work examines how health technologies reach the patients who need them. Access strategy determines whether an approved product is ever actually used.

Integrated Evidence Planning

Research examines coordinating evidence generation across regulatory and payer needs. Coordination prevents costly duplication and late evidence gaps.

Target Product Profile Research

Doctoral study examines defining what a product must achieve to succeed. Early definition directs development toward what payers will actually reward.

Value Proposition Development

Research examines articulating why a technology represents worthwhile value. Proposition clarity determines how evidence is assembled and presented.

Early Access Planning

Doctoral work examines access planning conducted long before any approval. Early planning shapes trial design while changes remain feasible.

Launch Sequencing Research

Research examines the order in which countries receive a new product. Sequencing decisions influence pricing across entire international markets.

Country Prioritisation Research

Doctoral study examines choosing where to seek access first. Prioritisation determines which populations gain access earliest and which wait.

Indication Sequencing Research

Research examines the order in which product uses are pursued for funding. Sequencing affects both evidence requirements and eventual pricing outcomes.

Lifecycle Management Research

Doctoral work examines maintaining access across a product commercial lifetime. Access conditions change substantially as competition eventually arrives.

Portfolio Strategy Research

Research examines access decisions across a whole product portfolio. Portfolio effects influence negotiation position across every individual product.

Competitive Landscape Analysis

Doctoral study examines assessing competing and emerging treatment options. Landscape assessment determines what comparison evidence will be demanded.

Standard Of Care Analysis

Research examines documenting what treatment patients currently actually receive. Real practice frequently differs markedly from published clinical guidance.

Unmet Need Assessment

Doctoral work examines demonstrating that existing options are inadequate. Unmet need argument underpins nearly every access submission made.

Burden Of Disease Analysis

Research examines quantifying the total harm that a condition causes. Burden evidence establishes why a condition deserves priority attention.

Epidemiology For Access

Doctoral study examines disease occurrence evidence supporting access submissions. Epidemiological estimates drive every population level projection made.

Patient Population Sizing

Research examines estimating how many patients are eligible for treatment. Population estimates determine projected expenditure and negotiating positions.

Market Forecasting Research

Doctoral work examines projecting future use of health technologies. Forecast accuracy determines both investment and supply planning decisions.

Uptake Modelling Research

Research examines how quickly clinicians adopt newly available treatments. Uptake speed differs enormously between countries and clinical settings.

Demand Estimation Research

Doctoral study examines projecting demand once access has been granted. Demand estimates underpin supply, capacity and expenditure planning.

Access Scenario Modelling

Research examines exploring possible access outcomes and their consequences. Scenario work prepares organisations for outcomes they did not expect.

Risk Assessment In Access

Doctoral work examines identifying what could prevent successful access. Early risk identification permits mitigation while options remain open.

Access Barrier Analysis

Research examines obstacles preventing patients from receiving approved treatments. Barriers operate at system, clinician and individual patient levels.

Payer Archetype Research

Doctoral study examines classifying the differing kinds of health purchasers. Purchaser type determines what evidence and arguments will persuade.

Payer Decision Research

Research examines how health purchasers actually reach funding decisions. Stated criteria frequently differ from what genuinely drives decisions.

Payer Engagement Research

Doctoral work examines interaction between developers and health purchasers. Engagement quality strongly affects both timing and access outcomes.

Early Purchaser Dialogue

Research examines discussion with purchasers before evidence generation concludes. Early dialogue prevents studies that fail to answer key questions.

Scientific Advice Research

Doctoral study examines formal advice sought during product development. Advice clarifies expectations while trial designs can still change.

Parallel Advice Research

Research examines regulators and assessment bodies advising developers together. Joint advice reduces conflicting evidence requirements considerably.

Evidence Requirement Mapping

Doctoral work examines documenting what each market demands as evidence. Requirements differ substantially between countries and assessment bodies.

Evidence Gap Analysis

Research examines identifying what evidence is missing before any submission. Gap identification permits generation while there is still time available.

Evidence Generation Planning

Doctoral study examines planning studies specifically for access purposes. Access evidence needs differ substantially from regulatory requirements.

Trial Design For Access

Research examines designing trials that satisfy purchaser evidence requirements. Trials designed only for approval frequently fail access assessment.

Comparator Selection Strategy

Doctoral work examines choosing what a new product is compared against. Comparator choice determines whether evidence answers the payer question.

Endpoint Selection For Access

Research examines choosing outcomes that purchasers regard as meaningful. Regulatory endpoints frequently fail to satisfy purchaser expectations.

Patient Relevant Endpoint Research

Doctoral study examines outcomes that matter directly to treated patients. Patient relevant outcomes increasingly determine access decisions made.

Quality Of Life Evidence Planning

Research examines collecting evidence on daily life impact of treatment. Quality of life data is essential yet frequently collected inadequately.

Real World Evidence Strategy

Doctoral work examines evidence generated from routine clinical practice. Routine practice evidence increasingly supplements trial based submissions.

Registry Strategy Research

Research examines organised data collections following treated patients. Registries provide long term evidence trials cannot practically generate.

Pragmatic Trial Research

Doctoral study examines trials conducted under routine practice conditions. Pragmatic designs produce evidence purchasers find directly relevant.

Indirect Comparison Strategy

Research examines comparing treatments never studied directly against each other. Indirect comparison is frequently the only evidence available.

Evidence Synthesis For Dossiers

Doctoral work examines combining evidence to support access submissions. Synthesis quality determines the credibility of submitted arguments.

Value Dossier Development

Research examines documents presenting the case for a product value. Dossier quality strongly influences how assessors approach a submission.

Global Value Dossier Research

Doctoral study examines central documents supporting submissions worldwide. Central documents ensure consistency while permitting local adaptation.

Local Adaptation Of Dossiers

Research examines adjusting central submissions for individual country requirements. Adaptation quality determines success within each separate market.

Submission Strategy Research

Doctoral work examines how and when access submissions are actually made. Timing and framing substantially affect the outcomes eventually achieved.

Pricing Strategy Research

Research examines how developers determine what to charge for products. Pricing decisions shape access, revenue and public perception together.

Value Based Pricing Research

Doctoral study examines pricing linked to demonstrated patient benefit. Value based approaches are widely advocated and inconsistently implemented.

Reference Pricing Research

Research examines pricing determined by reference to comparable products. Reference systems constrain pricing across entire therapeutic classes.

International Reference Analysis

Doctoral work examines countries setting prices by reference to other nations. Reference linkage means one decision propagates across many markets.

Price Corridor Research

Research examines maintaining acceptable price ranges across differing markets. Corridor management prevents low prices spreading through reference systems.

Launch Price Setting Research

Doctoral study examines determining the price at initial market entry. Launch pricing anchors expectations across the entire product lifetime.

Price Erosion Research

Research examines how achieved prices decline across a product lifetime. Erosion patterns strongly influence both commercial and access planning.

Discount Strategy Research

Doctoral work examines reductions offered from published list prices. Discounting is near universal and almost entirely undisclosed publicly.

Confidential Agreement Research

Research examines undisclosed terms within health purchasing agreements. Confidentiality obstructs comparison and weakens purchaser bargaining positions.

Published Versus Achieved Pricing

Doctoral study examines divergence between listed and actually paid amounts. This divergence makes published pricing data substantially misleading.

Price Transparency Research

Research examines disclosure of what health systems actually pay for treatments. Transparency proposals are contested by purchasers and suppliers alike.

Tender Strategy Research

Doctoral work examines competitive bidding processes for health products. Tender design determines both the value achieved and supply security.

Procurement Response Research

Research examines how suppliers respond to competitive purchasing processes. Response behaviour shapes market structure and long term supply.

Contracting Model Research

Doctoral study examines arrangements governing supply of health technologies. Contract design allocates risk between purchaser and supplier.

Managed Entry Agreement Design

Research examines arrangements permitting access under specified conditions. These arrangements bridge access and unresolved evidential uncertainty.

Outcome Based Agreement Research

Doctoral work examines payment linked to patient outcomes actually achieved. Outcome linkage is attractive yet very difficult to administer.

Performance Guarantee Research

Research examines suppliers guaranteeing specified treatment performance levels. Guarantees transfer performance risk from purchaser to supplier.

Risk Sharing Arrangement Research

Doctoral study examines dividing uncertainty between purchasers and suppliers. Risk sharing enables access despite genuinely unresolved evidence.

Financial Based Agreement Research

Research examines purely financial arrangements without outcome measurement. Financial schemes are simpler to administer than outcome linked ones.

Volume Agreement Research

Doctoral work examines arrangements linking terms to quantities supplied. Volume linkage aligns supplier and purchaser interests imperfectly.

Capitation Model Research

Research examines fixed payment covering all patients within a population. Population based payment shifts utilisation risk onto the supplier.

Subscription Model Research

Doctoral study examines paying for availability rather than quantity supplied. Subscription approaches suit antimicrobials and other public good products.

Instalment Payment Research

Research examines spreading payment for treatments across extended periods. Spreading suits single administration treatments with very high cost.

Annuity Model Research

Doctoral work examines continuing payments contingent on sustained benefit. Annuity structures link payment duration to observed treatment durability.

Warranty Model Research

Research examines suppliers refunding when treatments fail to work. Warranty arrangements address purchaser concern about durability uncertainty.

Rebate Mechanism Research

Doctoral study examines payments returned to purchasers following supply. Rebates preserve list prices while reducing what is genuinely paid.

Repayment Mechanism Research

Research examines suppliers returning funds when agreed limits are exceeded. Repayment arrangements protect purchaser budgets from unexpected volume.

Expenditure Cap Research

Doctoral work examines limits placed on total spending for one product. Caps provide purchaser certainty and constrain supplier revenue growth.

Budget Impact Negotiation

Research examines negotiation focused on total expenditure consequences. Affordability concerns frequently dominate value based arguments entirely.

Affordability Negotiation Research

Doctoral study examines negotiations where systems cannot fund at asked terms. Affordability and value are genuinely distinct considerations.

Threshold Negotiation Research

Research examines negotiation around acceptable value for resources committed. Thresholds are policy judgements frequently presented as technical facts.

Negotiation Process Research

Doctoral work examines how access negotiations are actually conducted. Process design strongly influences outcomes for both parties involved.

Negotiation Analytics

Research examines analytical support for access negotiation decisions. Analytics inform positions but cannot resolve genuine value disagreement.

Game Theoretic Approaches

Doctoral study examines formal modelling of strategic negotiation behaviour. Formal analysis clarifies incentives operating on each participating party.

Bargaining Power Research

Research examines relative strength of purchasers and suppliers in negotiation. Power imbalances determine outcomes more than evidence quality does.

Buyer Consortium Research

Doctoral work examines purchasers combining to strengthen their position. Combined purchasing substantially improves terms for smaller health systems.

Joint Procurement Research

Research examines countries purchasing health technologies collectively. Joint approaches pool both demand and negotiating expertise effectively.

Cross Country Negotiation

Doctoral study examines negotiation spanning several national health systems. Cross border approaches challenge established country by country practice.

Tiered Pricing Research

Research examines charging differently according to national income level. Tiering aims to widen access while preserving overall global revenue.

Equity Based Pricing Research

Doctoral work examines pricing structured around fairness in global access. Equity approaches remain contested and inconsistently implemented.

Voluntary Licensing Research

Research examines suppliers permitting others to produce their products. Licensing has substantially widened access for several key treatments.

Generic Entry Research

Doctoral study examines market entry of equivalent unbranded products. Entry produces the largest and most reliable reductions in treatment cost.

Biosimilar Entry Research

Research examines entry of follow on biological medicine products. Biological competition works differently from conventional generic entry.

Exclusivity Period Research

Doctoral work examines protection periods before competition may begin. Exclusivity duration determines when affordable competition can arrive.

Protection Expiry Research

Research examines commercial consequences when exclusivity protection ends. Expiry produces abrupt changes in both revenue and access conditions.

Portfolio Contracting Research

Doctoral study examines agreements spanning several products at once. Portfolio deals can obscure value assessment of the individual products.

Bundled Contracting Research

Research examines combining products and services within single agreements. Bundling complicates comparison and can restrict competitor entry.

Channel Strategy Research

Doctoral work examines routes through which products reach patients. Channel choice affects both access speed and achieved commercial terms.

Distribution Model Research

Research examines arrangements delivering products to treatment settings. Distribution design affects availability, wastage and total system expense.

Realised Value Analysis

Doctoral study examines the gap between listed terms and realised receipts. Understanding this gap is essential for any credible market analysis.

Assessment Body Interface

Research examines interaction between developers and technology assessment bodies. Interface management shapes how submissions are received and reviewed.

Assessment Submission Research

Doctoral work examines preparing evidence packages for formal assessment. Submission quality strongly determines the assessment outcome reached.

Assessment Response Research

Research examines responding to critique raised during formal assessment. Response quality can correct misunderstandings that would otherwise stand.

Appraisal Committee Engagement

Doctoral study examines interaction with committees reaching funding recommendations. Committee judgement resolves questions analysis cannot settle alone.

Evidence Review Group Interaction

Research examines independent academic critique of submitted evidence. Independent review routinely identifies substantial analytical problems.

Economic Model Development

Doctoral work examines building models supporting access submissions. Model construction requires balancing realism against transparency demands.

Model Structure Justification

Research examines defending the structural choices made within economic models. Structural choices frequently matter more than the input values used.

Cost Effectiveness Argument

Doctoral study examines arguing that benefits justify resources consumed. This argument underpins most formal access decisions internationally.

Budget Impact Modelling

Research examines projecting total expenditure consequences of adoption. Affordability is assessed separately from value for resources committed.

Uncertainty Communication Research

Doctoral work examines conveying analytical uncertainty to funding decision makers. Overstated certainty leads directly to poor funding decisions.

Sensitivity Analysis Strategy

Research examines exploring how assumptions affect submitted conclusions. Sensitivity work reveals which assumptions genuinely drive results.

Extrapolation Justification Research

Doctoral study examines projecting outcomes beyond observed trial periods. Extrapolation frequently drives conclusions more than observed data does.

Utility Evidence Research

Research examines preference values used within economic submissions. Value derivation substantially influences the conclusions models produce.

Preference Evidence Research

Doctoral work examines evidence about what patients and society genuinely value. Preference evidence increasingly features within access submissions.

Discrete Choice Evidence

Research examines preferences inferred from repeated hypothetical choices. Choice methods reveal trade offs people cannot easily articulate.

Patient Preference Research

Doctoral study examines what treated patients themselves actually value. Patient priorities frequently differ from clinical and payer assumptions.

Value Framework Research

Research examines structured frameworks defining what constitutes value. Framework choice determines which product attributes are actually rewarded.

Multicriteria Assessment Research

Doctoral work examines assessment weighing several value dimensions explicitly. These approaches make value judgements visible rather than hidden.

Broader Value Element Research

Research examines value dimensions conventional assessment methods omit. Omitted elements systematically disadvantage certain kinds of technology.

Societal Value Research

Doctoral study examines value accruing beyond the health system itself. Societal perspectives capture effects narrow assessment entirely excludes.

Caregiver Burden Evidence

Research examines effects of illness and treatment on unpaid family carers. Carer burden is substantial and routinely excluded from assessment.

Productivity Evidence Research

Doctoral work examines effects of treatment on the ability to work. Productivity effects are excluded from most narrow assessment perspectives.

Equity Value Research

Research examines whether treatments reduce or widen health inequalities. Distributional consequences are increasingly demanded within submissions.

Value Of Hope Research

Doctoral study examines value patients attach to a chance of exceptional benefit. Treatments with variable outcomes may carry value averages conceal.

Severity Weighting Research

Research examines giving greater weight to benefits in severe conditions. Severity weighting is applied explicitly in several assessment systems.

Rare Disease Value Assessment

Doctoral work examines assessment of treatments for very small populations. Conventional assessment methods fit these treatments extremely poorly.

Curative Therapy Valuation

Research examines valuing single administration potentially curative treatments. Durability remains unknown when funding decisions must be made.

Advanced Therapy Access Research

Doctoral study examines access for cell and gene based treatments. These treatments strain every assumption conventional access processes make.

Gene Therapy Access Research

Research examines access arrangements for genetic treatment products. Very high single payments require entirely new financing arrangements.

Cell Therapy Access Research

Doctoral work examines access for living cell based treatment products. Delivery requires specialised centres that substantially limit realistic access.

Diagnostic Access Research

Research examines securing funding for diagnostic tests and technologies. Diagnostics create value indirectly and are chronically undervalued.

Companion Diagnostic Access

Doctoral study examines tests determining eligibility for specific treatments. Test and treatment access must be secured together to work at all.

Digital Therapeutic Access

Research examines funding pathways for software based treatment products. Existing funding categories fit these products very imperfectly indeed.

Software Product Access Research

Doctoral work examines access for clinical software and automated tools. Frequent product revision sits badly with assessment assuming fixed technologies.

Device Market Access Research

Research examines access pathways for medical devices and equipment. Device access processes differ substantially from those used for medicines.

Vaccine Market Access Research

Doctoral study examines access arrangements for immunisation products. Vaccine benefits extend well beyond those who are actually vaccinated.

Combination Product Access

Research examines access where treatments are given in combination. Combination pricing raises unresolved attribution and affordability problems.

Antimicrobial Access Models

Doctoral work examines funding models suited to antimicrobial products. Conventional volume based models actively discourage antimicrobial development.

Pull Incentive Research

Research examines rewards offered for successfully developing needed products. Pull incentives address gaps that market demand alone leaves.

Push Incentive Research

Doctoral study examines support provided during product development itself. Development support reduces risk for neglected therapeutic areas.

Orphan Designation Research

Research examines special status granted to rare condition treatments. Designation confers commercial advantages that shape development choices.

Conditional Access Research

Doctoral work examines access granted subject to further evidence generation. Promised evidence is frequently delayed or never actually produced.

Coverage With Evidence Research

Research examines funding tied to structured data collection requirements. These schemes frequently fail to resolve the original uncertainty.

Reassessment Research

Doctoral study examines revisiting access decisions as evidence accumulates. Reassessment is rare because it is politically and practically difficult.

Disinvestment And Access

Research examines withdrawing funding from previously covered technologies. Withdrawal creates space for genuinely more beneficial treatments.

Health System Comparison Research

Doctoral work examines how access differs between national health systems. System structure determines which access strategies can possibly succeed.

Reimbursement System Research

Research examines arrangements through which treatments are funded. Reimbursement design determines who obtains treatment and under what conditions.

Positive List Research

Doctoral study examines lists specifying which treatments systems will fund. List inclusion is the decisive step within many national systems.

Restriction And Criteria Research

Research examines conditions limiting who may receive a funded treatment. Restrictions determine how many patients actually gain real access.

Prior Authorisation Research

Doctoral work examines approval requirements before treatment may be provided. Authorisation processes delay treatment and burden clinical staff.

Prescribing Control Research

Research examines mechanisms influencing what clinicians actually prescribe. Controls shape use more effectively than guidance alone achieves.

Regional Access Variation

Doctoral study examines differing access within a single country. Regional variation produces inequity despite identical national decisions.

Hospital Access Research

Research examines securing access within individual hospital settings. Hospital decisions can override or delay national funding recommendations.

Retail Access Research

Doctoral work examines access through community pharmacy and retail channels. Retail access reaches patients hospital pathways never encounter.

Access Pathway Research

Research examines the full route from approval through to patient treatment. Pathway length and complexity determine realised access in practice.

Time To Access Research

Doctoral study examines delay between approval and actual patient availability. Access delays differ enormously between countries and technologies.

Launch Delay Research

Research examines why products are not launched in particular markets. Deliberate non launch is a recognised and contested commercial strategy.

Access Deferral Research

Doctoral work examines postponing market entry pending favourable conditions. Deferral protects pricing while denying patients available treatment.

Withdrawal Decision Research

Research examines removing products from markets for commercial reasons. Commercial withdrawal can leave patients without any substitute treatment.

Regulatory Access Interface

Doctoral study examines relationships between approval and funding processes. Regulatory approval does not guarantee that patients receive treatment.

Accelerated Approval Access

Research examines access for products approved on preliminary evidence only. Early approval frequently produces prolonged disagreement about funding.

Evidence Standard Alignment

Doctoral work examines mismatch between regulatory and funding evidence needs. Misalignment forces duplicate studies and delays patient access.

Cross Border Access Research

Research examines patients seeking treatment outside their own country. Cross border movement reveals the consequences of access differences.

Named Patient Access Research

Doctoral study examines supply arranged for individual identified patients. Individual arrangements bypass systematic assessment processes entirely.

Compassionate Access Research

Research examines supply to seriously ill patients before formal approval. Compassionate supply raises difficult equity and evidence questions.

Early Access Programme Research

Doctoral work examines structured programmes providing pre approval treatment. Programmes accelerate access while generating supplementary evidence.

Expanded Access Research

Research examines broadening pre approval supply to larger patient groups. Expansion raises questions about evidence generation and about equity.

Reimbursement Policy Research

Doctoral study examines national policies governing what treatments are funded. Policy design shapes access more than individual decisions do.

Cost Containment Policy

Research examines measures restraining growth in health technology spending. Containment measures affect access alongside their intended savings.

Expenditure Control Research

Doctoral work examines mechanisms limiting total health technology expenditure. Controls create winners and losers among competing technologies.

Health Budget Allocation

Research examines distributing limited resources between competing health uses. Allocation decisions determine which patient groups gain and lose.

Political Economy Of Pricing

Doctoral study examines how power and interests shape pricing outcomes. Technical analysis alone never explains the pricing decisions observed.

Lobbying And Influence Research

Research examines industry influence over access and pricing policy making. Influence operates well beyond visible and declared lobbying activity.

Public Opinion And Access

Doctoral work examines public attitudes toward funding and pricing decisions. Public pressure can secure access outside systematic assessment.

Media And Access Debate

Research examines how access decisions are reported and framed publicly. Coverage frequently misrepresents both reasoning and available evidence.

Transparency Policy Research

Doctoral study examines disclosure requirements within access and pricing. Transparency proposals face resistance from multiple interested parties.

Ethics Of Pricing Research

Research examines ethical questions raised by health technology pricing. Pricing determines who lives and who does not in certain conditions.

Corporate Responsibility Research

Doctoral work examines developer obligations regarding global treatment access. Responsibility claims are frequently asserted and rarely independently verified.

Access Commitment Research

Research examines formal undertakings developers make about widening access. Commitment monitoring determines whether undertakings are actually honoured.

Trade Agreement Effects

Doctoral study examines how international trade rules influence treatment access. Trade provisions constrain what national access policies are permitted.

Access Analytics Research

Research examines quantitative analysis supporting access decisions. Analytics inform strategy but cannot resolve genuine value disagreement.

Data Sources For Access

Doctoral work examines datasets supporting access research and submissions. Data availability constrains what evidence can actually be generated.

Machine Learning In Access

Research applies learned models across access prediction and analysis tasks. Learned models must be validated against genuine decision outcomes.

Predictive Access Modelling

Doctoral study examines predicting access outcomes before submission. Prediction supports preparation but risks entrenching historic patterns.

Purchaser Sentiment Analysis

Research examines systematically assessing purchaser attitudes and priorities. Sentiment analysis informs how arguments should best be framed.

Natural Language Processing Applications

Doctoral work examines extracting information from assessment and policy documents. Automated extraction handles volumes manual review cannot manage.

Automated Evidence Review

Research examines automating identification and extraction of relevant evidence. Automation addresses the impossible literature volume to review.

Dossier Automation Research

Doctoral study examines automating preparation of access submission documents. Automation reduces effort while risking loss of tailored argument.

Model Reuse Research

Research examines adapting economic models across markets and submissions. Reuse saves effort but risks embedding inappropriate local assumptions.

Transparency In Modelling

Doctoral work examines disclosure of economic model structure and assumptions. Concealed models cannot be scrutinised or independently checked.

Reproducibility In Access Research

Research examines whether access analyses can be independently repeated. Many submitted analyses cannot be reproduced from their descriptions.

Methods Guidance Research

Doctoral study examines guidance defining acceptable analytical methods. Guidance shapes every submission that a body subsequently receives.

Access Research Standards

Research examines standards governing conduct of access related research. Standards determine whether submitted work can be properly evaluated.

Global Access Research

Doctoral work examines treatment availability across differing world regions. Access differences between regions are stark and persistently unaddressed.

Low Income Setting Access

Research examines treatment access where resources are severely constrained. Most patients worldwide live in exactly these constrained settings.

Middle Income Access Research

Doctoral study examines countries excluded from both preferential and premium arrangements. These countries frequently face the least favourable terms.

Access To Medicines Movement

Research examines civil society advocacy for wider treatment availability. Advocacy has measurably changed both pricing and licensing outcomes.

Health Equity In Access

Doctoral work examines fairness in who obtains the available treatments. Access inequity translates directly into unequal health outcomes for patients.

Underserved Population Access

Research examines groups persistently obtaining less benefit from treatments. Underserved groups are frequently absent from supporting evidence.

Patient Advocacy Research

Doctoral study examines patient organisations campaigning for treatment access. Advocacy influences outcomes and raises questions about funding sources.

Patient Involvement In Access

Research examines patient participation within access decision processes. Patient perspectives frequently differ from clinical and payer assumptions.

Access Communication Research

Doctoral work examines communicating access decisions to affected audiences. Explanation quality strongly affects acceptance of negative decisions.

Workforce And Capability Research

Research examines specialist skills required for access work. Specialist shortages constrain capability across purchasers and developers alike.

Organisational Capability Research

Doctoral study examines how organisations build access related capability. Capability determines whether good strategy can actually be executed.

Implementation Of Access Strategy

Research examines why access strategies succeed or fail during execution. Implementation, not strategy design, is where most value is actually lost.